2019/02/21DiQi Pharma Congratulates Tian’an Pharma on Metformin Hydrochloride Tablets Passing China’s Generic Drug Consistency Evaluation
On February 19, 2019, Boya Bio-Pharmaceutical Co., Ltd. announced that its controlling subsidiary, Guizhou Tian'an Pharmaceutical Co., Ltd. (hereinafter referred to as “Tian'an Pharmaceutical”), received the “Drug Supplementary Application Approval Document” issued by the China Food and Drug Administration for Metformin Hydrochloride Tablets (Specification: 0.25g). This drug has passed the consistency evaluation of quality and efficacy for generic drugs.
